Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ozempic and other semaglutide medications have skyrocketed in popularity as weight-loss aids, with prescriptions surging by ...

The type 2 diabetes medication, generically known as semaglutide ... weight loss-independent mechanisms through which GLP-1 reduces inflammation — is it through the brain, or via T cells, or ...

New data suggests that the benefits of Novo Nordisk’s GLP-1 agonist semaglutide in preventing cardiovascular diseases may not simply be a result of weight loss. The analysis comes from long-term ...

Share on Pinterest Ozempic (semaglutide ... There are many other ways to lose weight and maintain weight loss that are more affordable and have fewer side effects than weight loss medications ...

making it difficult to purchase semaglutide. She had already begun reducing her dosages, cutting back on the weekly injections to maintain, rather than lose, weight. “I was miserable ...

Compounding is when pharmacies or other practitioners ... and sale of compounded semaglutide. “We are aware that several compounding pharmacies, weight loss clinics, and medical spas are ...

A new study, the first to catalogue these risks and benefits ... and Wegovy for weight loss. The company said it's exploring the use of semaglutide, a type of GLP-1, for other diseases such ...